Minbos Resources Finalizes $2.61 Million Placement with 174 Million New Shares Issued

Placement Overview and Capital Structure Post-Tranche One

Minbos Resources Limited has formally applied for quotation of 174,275,639 fully paid ordinary shares issued on 24 July 2026 at AUD $0.015 per share. This placement raised approximately AUD $2.61 million in gross proceeds, representing a significant capital injection aligned with the company’s broader funding strategy announced on 20 July 2026.

The placement reflects Minbos Resources’ efforts to bolster its balance sheet and support strategic or operational objectives. The issue price aligns with prevailing market conditions and investor demand at the time of placement. While the quotation application does not specify the use of proceeds, investors can refer to the 20 July 2026 company update for insights into capital deployment plans.

Capital Position and Security Classes After Quotation

Following quotation of the 174,275,639 shares, Minbos Resources’ total ordinary fully paid shares on issue will increase to 1,336,113,237. This marks a notable expansion in the company’s share capital. The capital structure also includes several quoted option classes with varying expiry dates and exercise prices, alongside unquoted options, indicating a diversified approach to funding and incentives.

Quoted options include 38,571,429 expiring 20 December 2026, 84,490,270 expiring 16 March 2029, and 117,864,951 expiring 15 December 2028. Additionally, there are 3,333,333 unquoted options expiring 9 April 2027 with an exercise price of AUD $0.10. This layered structure is typical for ASX-listed companies employing staged capital raises and equity-linked incentive schemes, balancing investor returns with employee and adviser incentives.

Second Tranche Placement Pending Shareholder Approval

The capital raise includes a second tranche involving further placement shares, placement options, lead manager options, and adviser options, all subject to shareholder approval at an upcoming General Meeting, with the date yet to be announced. This phased approach allows the company to secure necessary regulatory and shareholder consents before issuing additional securities.

The inclusion of lead manager and adviser options suggests financial intermediaries facilitated the placement, potentially receiving equity as part of their fees. Details regarding the number, pricing, and terms of Tranche Two securities will be disclosed prior to the General Meeting, and shareholders should monitor company communications for updates.

Cash Placement and Execution Details

The placement was conducted entirely for cash consideration in Australian dollars at AUD $0.015 per share, raising approximately AUD $2.61 million in the first tranche. This moderate raise size suggests participation primarily from smaller domestic investors or a deliberate staged approach to minimize market impact and maintain share price stability.

The quotation application confirms these shares are fully paid with no additional liabilities. Specific holder distribution details were not disclosed at the time of application, which is common when shares are quoted prior to final registry updates.

Timeline and Announcement Summary

The capital raise was announced on 20 July 2026, with the first tranche shares issued on 24 July 2026, just four days later. The quotation application was lodged on 27 July 2026, following a typical three-business-day interval between issue and quotation application.

This swift timeline indicates a pre-arranged placement well received by targeted investors. The rapid execution suggests thorough preparation of placement documentation and investor terms prior to public disclosure, limiting market reaction time.

Shareholder Dilution and Capital Management Implications

The issuance of 174.3 million shares in Tranche One significantly increases MNB’s share count to over 1.33 billion, resulting in material dilution for existing shareholders. Although the exact dilution percentage is not specified, the scale of the raise indicates substantial impact.

The staged capital raise structure with Tranche Two pending shareholder approval provides an opportunity for shareholders to assess the use of proceeds and strategic rationale before full dilution occurs. Investors should evaluate whether the capital raised supports value-enhancing initiatives that justify the dilution.

Background and Transaction Context

The quotation application references an Appendix 3B lodged on 20 July 2026 titled "New - Proposed issue of securities - MNB," which details the rationale, timing, and conditions of the capital raise. Investors seeking comprehensive information should consult this update.

The use of an Appendix 3B filing indicates the placement targeted sophisticated investors rather than a public offer, consistent with the staged approach and inclusion of lead manager and adviser options, reflecting professional capital raising intermediaries.

Market Reaction and Share Price Considerations

The quotation application does not provide information on immediate share price impact or trading activity. Market response likely occurred in the days following the 20 July 2026 announcement. Investors should review historical ASX data and independent reports for trading performance relative to the AUD $0.015 placement price, which serves as a benchmark for investor sentiment.

Regulatory Compliance and Quotation Process

The quotation application complies with ASX Listing Rules Appendix 2A, governing securities quotation on the Australian Securities Exchange. Minbos Resources Limited (ACN 141175493, ASX code MNB) has confirmed adherence to all relevant requirements, ensuring accurate and complete disclosure.

Approval of this application will enable holders of the 174,275,639 new shares to trade them on the ASX, providing liquidity and transferability to placement participants.